Urothelial (transitional cell) papilloma of the urinary bladder: A clinicopathologic study of 26 cases

Modern Pathology

Volumn 16, Issue 7, 2003, Pages 623-629

  McKenney, Jesse K ^a   Amin, Mahul B ^a,c   Young, Robert H ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Benign; Classification; Grading; Neoplasm; Papillary carcinoma; Papilloma; Transitional cell; Urinary bladder; Urothelial papilloma

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER PAPILLOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MORPHOLOGY; MORTALITY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

ADULT; AGED; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMA; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0038107640     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000073973.74228.1E     Document Type: Article

References (10)

1. Eble JN, Young RH. Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas. Semin Diagn Pathol 1989;6:351-71.
2. Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladder tumors. International histological classification of tumors. No. 10. Geneva, Switzerland: World Health Organization; 1973.
3. Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-48.
4. Kunze E, Schauer A, Schmitt M. Histology and histogenesis of two different types of inverted papillomas. Cancer 1983;51:348-58.
5. Taylor DC, Bhagavan BS, Larsen MP, Cox JA, Epstein JI. Papillary urothelial hyperplasia. A precursor to papillary neoplasms. Am J Surg Pathol 1996;20:1481-8.
6. Cheng L, Darson M, Cheville JC, et al. Urothelial papilloma of the bladder. Clinical and biologic implications. Cancer 1999;86:2098-101.
7. Orozco RE, Martin AA, Murphy WM. Carcinoma in situ of the urinary bladder. Clues to host involvement in human carcinogenesis. Cancer 1994;74:115-22.
8. Desai S, Lim SD, Jimenez RE, et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol 2000;13:1315-23.
9. Harnden P, Mahmood N, Southgate J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 1999;353:974-7.
10. Chow N, Cairns P, Eisenberger CF, et al. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 2000;89:514.